MedAvail Holdings, Inc.

MDVLQ Healthcare Pharmaceutical Retailers

Revenue growth for five consecutive years.

0.00 0.00 NaN
Market cap
$2.9M
P/E
0.0×
Fwd P/E
−1.0×
Dividend yield
—
F-score
4/9
Altman Z
−11.84
Beneish M
−2.09
Dividend safety
n/a

MedAvail Holdings, Inc. (MDVLQ) EV/Sales

Alert me on EV/Sales

As of 15 October 2026, MedAvail Holdings, Inc. (MDVLQ) trades at a EV/Sales of −0.3×. Over the past ten years it has ranged from −0.3× (October 2026) to 94.4× (January 2017) — the current reading is the lowest in ten years. That is below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2022 0.3× (82.20%)
FY2022 1.7× 2.74%
FY2021 1.6× (20.54%)
FY2021 2.1× (7.03%)
FY2020 2.2× (70.57%)
FY2020 7.5× 0.69%
FY2019 7.5× (74.18%)
FY2019 28.9× 2.82%
FY2018 28.1× 100.77%
FY2018 14.0× 0.00%

Quarterly newest first

Period EV/Sales Change
Jun 2023 0.2× 60.06%
Mar 2023 0.1× (54.10%)
Dec 2022 0.3× (87.01%)
Sep 2022 2.3× (63.24%)
30 more quarters

Against its own ten years

Low −0.3× High 94.4×
Ten-year median 4.3×
Current reading's percentile 21

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MDVLQ